| Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression : Results Through Week 144 of the SIMPL'HIV Trial | Open forum infectious diseases |  | | 2024 | 10 | 94 |
|
| Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy : the SIMPL'HIV open-label, factorial randomised controlled trial | Swiss medical weekly | | | 2024 | 18 | 92 |
|
| Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial | British journal of clinical pharmacology |  | | 2021 | 227 | 0 |
|
| Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial | PLoS medicine | | | 2020 | 233 | 264 |
|
| Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis | F1000Research | | | 2018 | 163 | 268 |
|
| Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study | HIV Medicine | | | 2018 | 341 | 148 |
|
| Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study | BMC Infectious Diseases | | | 2017 | 429 | 190 |
|
| Is monotherapy maintenance the way forward ? | The lancet. HIV | | | 2015 | 72 | 107 |
|
| Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literature | Journal of the International AIDS Society | | | 2014 | 590 | 460 |
|
| Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approach | Journal of the International AIDS Society | | | 2014 | 627 | 1,400 |
|
